Team:Tsinghua/Design2

From 2009.igem.org

(Difference between revisions)
(→Synthesis of Therapeutic DNA)
(→Synthesis of Therapeutic DNA)
Line 3: Line 3:
-
Here we introduce another molecular cloning vector to mimic the bacteriophage lambda genome which will be packaged into the viroin. What’s more, the synthetic “bacteriophage lambda genome” contains the therapeutic gene(s) needed by the target cells, which will be transported via simulated viral introduction.
+
Here we introduce another molecular cloning vector to mimic the bacteriophage lambda genome which will be packaged into the virion. What’s more, the synthetic “bacteriophage lambda genome” contains the therapeutic gene(s) needed by the target cells, which will be transported via simulated viral introduction.
-
We term this molecular cloning vector “Therapeutic DNA”, which consists of a cos site for the package into the viroin of targeted gene therapy vector, the therapeutic gene(s) for in vivo gene therapy and the replication origin of bacteriophage lambda (including O gene and P gene).
+
We term this molecular cloning vector “Therapeutic DNA”, which consists of a cos site for the package into the virion.The therapeutic gene is for in vivo gene therapy and owns the replication origin of bacteriophage lambda (including O gene and P gene).

Revision as of 03:11, 21 October 2009

Synthesis of Therapeutic DNA

Cosmid.png


Here we introduce another molecular cloning vector to mimic the bacteriophage lambda genome which will be packaged into the virion. What’s more, the synthetic “bacteriophage lambda genome” contains the therapeutic gene(s) needed by the target cells, which will be transported via simulated viral introduction.

We term this molecular cloning vector “Therapeutic DNA”, which consists of a cos site for the package into the virion.The therapeutic gene is for in vivo gene therapy and owns the replication origin of bacteriophage lambda (including O gene and P gene).

Retrieved from "http://2009.igem.org/Team:Tsinghua/Design2"